Kossel Medtech (Suzhou) Co., Ltd., a company specializing in coronary and peripheral intervention medical devices, electrophysiology series products, and related accessories, has reportedly secured over RMB 100 million (USD 14 million) in a Series B funding round. The round was led by Fortune Capital, with additional investments from SIDVC, SND, and Medpark. The funds raised will be allocated to enhance the platformization and international reach of the company’s vascular intervention products, pipeline candidates, and manufacturing capabilities.
Kossel Medtech expanded its international presence at the end of 2021 by acquiring MiCell Technologies Ireland Ltd and announced plans to establish a production base and R&D center in the United States.- Fineline.com
